You have tolerated GLP-1 medications well previously
Retatrutide inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively
The blood pressure-lowering effect appears to be primarily mediated through weight loss
GLP-1 receptor agonistsmedications approved for type 2 diabetes and obesityare sometimes used at very low doses in the hope of reducing side effects whilst addressing weight gain and metabolic symptoms common in Hashimoto's thyroiditis
But until recently, going through telehealth companies that sourced drugs from compounding pharmacies might have been the only way somebody could get, and stay, on a GLP-1 medication
Di Micco, R., Krizhanovsky, V., Baker, D